<ul data-eligibleForWebStory="false"><li>Anthem Biosciences issue, entirely an offer-for-sale by promoters and investors, opens at a price band of ₹540-570.</li><li>The IPO has reservations for retail investors, QIBs, and HNIs.</li><li>Anthem Biosciences, an innovation-driven CRDMO, raised ₹1,016 crore from anchor investors ahead of its public share-sale.</li><li>The company, with integrated drug discovery and manufacturing operations, has notable investors and peers in the industry.</li></ul>

Anthem Biosciences issue opens today in a price band of ₹540-570

Discover more